Between January 29 and January 31, 2025, Dr. Agarwal's Healthcare, a well-known company in the eye care industry, is set to launch its initial public offering (IPO). With an estimated valuation between ₹12,700 crores and ₹12,900 crores, this initial public offering (IPO) is notable as it aims to raise approximately ₹3,027.26 crores. The organization has gained recognition for offering a wide variety of eye care services and runs a large network of eye hospitals across India.
Read more: Cyient Shares Q3 Results
Pricing Details
The price range of the initial public offering (IPO) has been fixed at ₹382 to ₹402 per share. A minimum lot size of 35 shares will be available for investors to apply for which the application fee will be around ₹14,070. The IPO comprises a fresh issue of equity shares worth ₹300 crore apart from an offer for sale of around 6.78 crore equity shares by promoters and investors.
Main Dates
The IPO subscription period will commence on January 29, 2025 and will end on January 31, 2025. Once the allotment basis is determined on February 3, the refund process will start by February 4. Ahead of the listing date on February 5, 2025, on both BSE and NSE, the shares are expected to be credited to investors' demat accounts on the same day.
Market Valuation and Performance
Ahead of its first public offering (IPO), Dr. Agarwal's Healthcare announced strong financial performance. The firm has total assets of ₹3,393.41 crore, revenue of ₹837.94 crore and profit after taxes of ₹39.56 crore as of September 30, 2024. This solid financial foundation supports its market value and reflects its expansion in the healthcare industry.
In the last year alone, the company has performed over 220,000 procedures, treated over 2.13 million patients, and has over 193 clinics across 117 Indian cities. This wide reach reflects Dr. Agarwal's dedication to providing easily accessible eye care services across the country.
Investment Considerations
Investors looking to participate in this IPO should consider the growth potential of Dr. Agarwal Healthcare in the growing Indian healthcare sector. The business is well positioned against competitors in the industry due to its well-established presence and efficient operations.
In conclusion, investors have a chance to interact with a top healthcare provider that is well positioned for future growth and support its expansion goals by investing in the Dr. Agarwal Healthcare IPO to the public.
Keep following 5 Dariya News for more news and articles.